The clinical course of a case of primary thrombocythemia is described, complicated by a variety of recurrent and sequential thrombotic manifestations, involving the peripheral as well as the cerebrovascular and coronary microvasculature, demonstrating that throm bocythemia should be considered as an important risk factor for thrombosis, already at platelet count states in excess of 400 x 109/L.
Get full access to this article
View all access options for this article.
References
1.
Schafer AI: Essential thrombocythemia. In: Progress in Hemostasis and Thrombosis , ed. by Coller BS.Philadelphia: WB Saunders, 10:69-96, 1991.
2.
Van Genderen PJJ , Michiels JJ: Primary thrombocythemia — diagnosis, clinical manifestations and management. Ann Hematol67:57-62, 1993.
3.
Michiels JJ, ten Kate Fwj, Vuzevski VD, et al: Histopathology of erythromelalgia in thrombocythemia. Histopathology8:669-678, 1984.
4.
Michiels JJ, Abels J., Steketee J., et al: Erythromelalgia caused by platelet-mediated arteriolar inflammation and thrombosis in thrombocythemia. Ann Intern Med102:466-471, 1985.
5.
Michiels JJ, van Joost Th: Erythromelalgia and thrombocythemia, a causal relation. J Am Acad Dermatol22:107-111, 1990.
6.
Van Genderen Pjj, Michiels JJ, Drenth Jph: Hereditary erythermalgia and acquired erythromelalgia . Am J Med Gen45:530-531, 1993.
7.
Scheffer MG, Michiels JJ, Simoons ML, et al: Thrombocythemia and coronary artery disease. Am Heart J122:573-576, 1991.
8.
Michiels JJ, Koudstaal PJ, Mulder AH, et al: Transient neurological and ocular manifestations in primary thrombocythemia. Neurology43:1107-1110, 1993.
